Home › Steatotic Liver Disease › Kentucky
Steatotic Liver Disease clinical trials in Kentucky
4 studies for Steatotic Liver Disease are looking for participants at sites in Kentucky.
Cities in Kentucky
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Louisville
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Nov 12, 2026 · NCT06528314A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Louisville
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Oct 23, 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Louisville
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 23, 2026 · NCT06318169A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- AMR Clinical, Lexington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT07165028From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.